Aufbau und Charakterisierung eines flugzeuggetragenen Einzelpartikel-Massenspektrometers

Im Rahmen dieser Arbeit wurde ein flugzeuggetragenes Laserablations-Einzelpartikel-Massenspektrometer von Grund auf entworfen, gebaut, charakterisiert und auf verschiedenen Feldmesskampagnen eingesetzt. Das ALABAMA (Aircraft-based Laser ABlation Aerosol MAss Spectrometer) ist in der Lage die chemische Zusammensetzung und Größe von einzelnen Aerosolpartikeln im submikrometer-Bereich (135 – 900 nm) zu untersuchen.rnNach dem Fokussieren in einer aerodynamischen Linse wird dafür zunächst derrnaerodynamische Durchmesser der einzelnen Partikel mit Hilfe einer Flugzeitmessung zwischen zwei Dauerstrichlasern bestimmt. Anschließend werden die zuvor detektierten und klassifizierten Partikel durch einen gezielten Laserpuls einzeln verdampft und ionisiert. Die Ionen werden in einem bipolaren Flugzeit-Massenspektrometer entsprechend ihrem Masse zu- Ladungs Verhältnisses getrennt und detektiert. Die entstehenden Massenspektren bieten einen detaillierten Einblick in die chemische Struktur der einzelnen Partikel.rnDas gesamte Instrument wurde so konzipiert, dass es auf dem neuen Höhenforschungsflugzeug HALO und anderen mobilen Plattformen eingesetzt werden kann. Um dies zu ermöglichen wurden alle Komponenten in einem Rahmen mit weniger als 0.45 m³ Volumen untergebracht. Das gesamte Instrument inklusive Rahmen wiegt weniger als 150 kg und erfüllt die strengen sicherheitsvorschriften für den Betrieb an Bord von Forschungsflugzeugen. Damit ist ALABAMA das kleinste und leichteste Instrument seiner Art.rnNach dem Aufbau wurden die Eigenschaften und Grenzen aller Komponenten detailliert im Labor und auf Messkampagnen charakterisiert. Dafür wurden zunächst die Eigenschaften des Partikelstrahls, wie beispielsweise Strahlbreite und –divergenz, ausführlich untersucht. Die Ergebnisse waren wichtig, um die späteren Messungen der Detektions- und Ablationseffizienz zu validieren.rnBei den anschließenden Effizienzmessungen wurde gezeigt, dass abhängig von ihrer Größe und Beschaffenheit, bis zu 86 % der vorhandenen Aerosolpartikel erfolgreich detektiert und größenklassifiziert werden. Bis zu 99.5 % der detektierten Partikel konnten ionisiert und somit chemisch untersucht werden. Diese sehr hohen Effizienzen sind insbesondere für Messungen in großer Höhe entscheidend, da dort zum Teil nur sehr geringe Partikelkonzentrationen vorliegen.rnDas bipolare Massenspektrometer erzielt durchschnittliche Massenauflösungen von bis zu R=331. Während Labor- und Feldmessungen konnten dadurch Elemente wie Au, Rb, Co, Ni, Si, Ti und Pb eindeutig anhand ihres Isotopenmusters zugeordnet werden.rnErste Messungen an Bord eines ATR-42 Forschungsflugzeuges während der MEGAPOLI Kampagne in Paris ergaben einen umfassenden Datensatz von Aerosolpartikeln innerhalb der planetaren Grenzschicht. Das ALABAMA konnte unter harten physischen Bedingungen (Temperaturen > 40°C, Beschleunigungen +/- 2 g) verlässlich und präzise betrieben werden. Anhand von charakteristischen Signalen in den Massenspektren konnten die Partikel zuverlässig in 8 chemische Klassen unterteilt werden. Einzelne Klassen konnten dabei bestimmten Quellen zugeordnet werden. So ließen sich beispielsweise Partikel mit starkerrnNatrium- und Kaliumsignatur eindeutig auf die Verbrennung von Biomasse zurückführen.rnALABAMA ist damit ein wertvolles Instrument um Partikel in-situ zu charakterisieren und somit verschiedenste wissenschaftliche Fragestellungen, insbesondere im Bereich der Atmosphärenforschung, zu untersuchen.

Untersuchungen von Aerosolpartikeln und Wolkenresidualpartikeln mittels Einzelpartikel-Massenspektrometrie und optischen Methoden

Atmosphärische Partikel beeinflussen das Klima durch Prozesse wie Streuung, Reflexion und Absorption. Zusätzlich fungiert ein Teil der Aerosolpartikel als Wolkenkondensationskeime (CCN), die sich auf die optischen Eigenschaften sowie die Rückstreukraft der Wolken und folglich den Strahlungshaushalt auswirken. Ob ein Aerosolpartikel Eigenschaften eines Wolkenkondensationskeims aufweist, ist vor allem von der Partikelgröße sowie der chemischen Zusammensetzung abhängig. Daher wurde die Methode der Einzelpartikel-Laserablations-Massenspektrometrie angewandt, die eine größenaufgelöste chemische Analyse von Einzelpartikeln erlaubt und zum Verständnis der ablaufenden multiphasenchemischen Prozesse innerhalb der Wolke beitragen soll.rnIm Rahmen dieser Arbeit wurde zur Charakterisierung von atmosphärischem Aerosol sowie von Wolkenresidualpartikel das Einzelpartikel-Massenspektrometer ALABAMA (Aircraft-based Laser Ablation Aerosol Mass Spectrometer) verwendet. Zusätzlich wurde zur Analyse der Partikelgröße sowie der Anzahlkonzentration ein optischer Partikelzähler betrieben. rnZur Bestimmung einer geeigneten Auswertemethode, die die Einzelpartikelmassenspektren automatisch in Gruppen ähnlich aussehender Spektren sortieren soll, wurden die beiden Algorithmen k-means und fuzzy c-means auf ihrer Richtigkeit überprüft. Es stellte sich heraus, dass beide Algorithmen keine fehlerfreien Ergebnisse lieferten, was u.a. von den Startbedingungen abhängig ist. Der fuzzy c-means lieferte jedoch zuverlässigere Ergebnisse. Darüber hinaus wurden die Massenspektren anhand auftretender charakteristischer chemischer Merkmale (Nitrat, Sulfat, Metalle) analysiert.rnIm Herbst 2010 fand die Feldkampagne HCCT (Hill Cap Cloud Thuringia) im Thüringer Wald statt, bei der die Veränderung von Aerosolpartikeln beim Passieren einer orographischen Wolke sowie ablaufende Prozesse innerhalb der Wolke untersucht wurden. Ein Vergleich der chemischen Zusammensetzung von Hintergrundaerosol und Wolkenresidualpartikeln zeigte, dass die relativen Anteile von Massenspektren der Partikeltypen Ruß und Amine für Wolkenresidualpartikel erhöht waren. Dies lässt sich durch eine gute CCN-Aktivität der intern gemischten Rußpartikel mit Nitrat und Sulfat bzw. auf einen begünstigten Übergang der Aminverbindungen aus der Gas- in die Partikelphase bei hohen relativen Luftfeuchten und tiefen Temperaturen erklären. Darüber hinaus stellte sich heraus, dass bereits mehr als 99% der Partikel des Hintergrundaerosols intern mit Nitrat und/oder Sulfat gemischt waren. Eine detaillierte Analyse des Mischungszustands der Aerosolpartikel zeigte, dass sich sowohl der Nitratgehalt als auch der Sulfatgehalt der Partikel beim Passieren der Wolke erhöhte. rn

The physician's perception of medical error and its application to the development of an educational training tool.

It is becoming clear that if we are to impact the rate of medical errors it will have to be done at the practicing physician level. The purpose of this project was to survey the attitude of physicians in Alabama concerning their perception of medical error, and to obtain their thoughts and desires for medical education in the area of medical errors. The information will be used in the development of a physician education program.

Studies of the structure and function of a fibrinogen binding MSCRAMM(RTM) from Staphylococcus epidermidis

Coagulase-negative staphylococci (CNS) are recognized as important pathogens and are particularly associated with foreign body infections. S. epidermidis accounts for approximately 75% of the infections caused by CNS. Three genes, sdrF, sdrG, and sdrH, were identified by screening a S. epidermidis genomic library with a probe encompassing the serine-aspartate dipeptide repeat-encoding region (region R) of clfA from S. aureus. SdrG has significant amino acid identity to ClfA, ClfB and other surface proteins of S. aureus. SdrG is also similar to a protein (Fbe) recently described by Nilsson, et al. (Infection and Immunity, 1998, 66:2666–73) from S. epidermidis. The N-terminal domain (A region) of SdrG was expressed as a his-tag fusion protein in E. coli. In an ELISA, this protein, rSdrG(50-597) was shown to bind specifically to fibrinogen (Fg). Western ligand blot analysis showed that SdrG binds the Bβ chain of Fg. To further characterize the rSdrG(50-597)-Fg interaction, truncates of the Fg Bβ chain were made and expressed as recombinant proteins in E. coli. SdrG was shown to bind the full-length Bβ chain (1462), as well as the N-terminal three-quarters (1-341), the N-terminal one-half (1-220) and the N-terminal one-quarter (1-95) Bβ chain constructs. rSdrG(50-597) failed to bind to the recombinant truncates that lacked the N-terminal 25 amino acid residues of this polypeptide suggesting that SdrG recognizes a site within this region of the Bβ chain. Inhibition ELISAs have shown that peptide mimetics, including β1–25, and β6–20, encompassing this 25 residue region can inhibit binding of rSdrG(50-597) to Fg coated wells. Using fluorescence polarization we were able to determine an equilibrium constant (KD) for the interaction of rSdrG(50-597) with the Fg Bβ chain peptide β1–25. The labeled peptide was shown to bind to rSdrG(50-597) with a KD of 0.14 ± 0.01μM. Because rSdrG(50-597) recognizes a site in the Fg Bβ chain close to the thrombin cleavage site, we investigated the possibility of the rSdrG(50-597) site either overlapping or lying close to this cleavage site. An ELISA showed that rSdrG(50-597) binding to thrombin-treated Fg was significantly reduced. In a clot inhibition assay rSdrG(50-597) was able to inhibit fibrin clot formation in a concentration dependent manner. Furthermore, rSdrG(50-597) was able to inhibit clot formation by preventing the release of fibrinopeptide B as determined by HPLC. To further define the interaction between rSdrG(50-597) and peptide β6–20, we utilized an alanine amino acid replacement strategy. The residues in β6–20 that appear to be important in rSdrG(50-597) binding to Fg, were confirmed by the rSdrG(273-597)-β6–20 co-crystal structure that was recently solved by our collaborators at University of Alabama-Birmingham. Additionally, rSdrG(50-597) was not able to bind to Fg from different animal species, rather it bound specifically to human Fg in an ELISA. This suggests that the sequence variation between Fg Bβ chains of different species, specifically with in the N-terminal 25 residues, affects the ability of rSdrG(50-597) binding to Fg, and this may explain why S. epidermidis is primarily a human pathogen. ^

Statins and myasthenia gravis

Introduction. 3-hydroxy-3-methylglutaryl CoA reductase inhibitor ("statin") have been widely used for hypercholesteroremia and Statin induced myopathy is well known. Whether Statins contribute to exacerbation of Myasthenia Gravis (MG) requiring hospitalization is not well known. ^ Objectives. To determine the frequency of statin use in patients with MG seen at the neuromuscular division at University of Alabama in Birmingham (UAB) and to evaluate any association between use of statins and MG exacerbations requiring hospitalization in patients with an established diagnosis of Myasthenia Gravis. ^ Methods. We reviewed records of all current MG patients at the UAB neuromuscular department to obtain details on use of statins and any hospitalizations due to exacerbation of MG over the period from January 1, 2003 to December 31, 2006. ^ Results. Of the 113 MG patients on whom information was available for this period, 40 were on statins during at least one clinic visit. Statin users were more likely to be older (mean age 60.2 vs 53.8, p = 0.029), male (70.0% vs 43.8%, p = 0.008), and had a later onset of myasthenia gravis (mean age in years at onset 49.8 versus 42.9, p = 0.051). The total number of hospitalizations or the proportion of subjects who had at least one hospitalization during the study period did not differ in the statin versus no-statin group. However, when hospitalizations which occurred from a suspected precipitant were excluded ("event"), the proportion of subjects who had at least one such event during the study period was higher in the group using statins. In the final Cox proportional hazard model for cumulative time to event, statin use (OR = 6.44, p <0.01) and baseline immunosuppression (OR = 3.03, p = 0.07) were found to increase the odds of event. ^ Conclusions. Statin use may increase the rate of hospitalizations due to MG exacerbation, when excluding exacerbations precipitated by other suspected factors.^

The association of peer victimization and/or bullying perpetration and body dissatisfaction in elementary students from the healthy passages baseline study

This is the first U.S. study to investigate the association between peer victimization and/or bullying perpetration and body image dissatisfaction in American elementary school students. The study used data collected from the Healthy Passages baseline cohort of 5152 ethnically diverse fifth grade students from Alabama, Texas, and California. The overall prevalence of body dissatisfaction in our fifth grade sample was 50%. Students who were dissatisfied with their bodies were 23% more likely to be involved in peer victimization than students who were satisfied with their bodies (OR = 1.23; 95% CI = 1.02, 1.48). No significant associations were found between bullying status or bully-victim status and body dissatisfaction. Other factors that contributed significantly to a student's body image status were BMI, level of self-worth, level of household income, gender, pubertal timing and support received from adults (other than parents). It is noteworthy that those who were dissatisfied were heavier, came from lower income homes and were more likely to be male. Additional longitudinal studies are needed to confirm these associations, especially among large ethnically and socio-economically diverse samples. ^

Birth prevalence of isolated congenital limb reduction defects in Texas 1999--2001

Objective. Congenital limb defects are common birth defects occurring in approximately 2-7/10,000 live births. Because congenital limb defects are pervasive throughout all populations, and the conditions profoundly affect quality of life, they represent a significant public health concern. Currently there is a paucity of etiologic information in the literature regarding congenital limb reduction defects which represents a major limitation in developing treatment strategies as well as identifying high risk pregnancies. ^ Additionally, despite the fact that the majority of congenital limb reduction defects are isolated, most previous studies have not separated them from those occurring as part of a known syndrome or with multiple additional congenital anomalies of unknown etiology. It stands to reason that factors responsible for multiple congenital anomalies that happen to include congenital limb reduction defects may be quite different from those factors leading to an isolated congenital limb reduction defect. ^ As a first step toward gaining etiologic understanding, this cross-sectional study was undertaken to determine the birth prevalence and obtain demographic information about non-syndromic (isolated) congenital limb reduction defects that occurred in Texas from 1999-2001. ^ Methods. The study population included all infants/fetuses with isolated congenital limb reduction defects born in Texas during 1999-2001; the comparison population was all infants who were born to mothers who were residents of Texas during the same period of time. The overall birth prevalence of limb reduction defects was determined and adjusted for ethnicity, gender, site of defect (upper limb versus lower limb), county of residence, maternal age and maternal education. ^ Results. In Texas, the overall birth prevalence of isolated CLRDs was 2.1/10,000 live births (1.5 and 0.6/10,000 live births for upper limb and lower limb, respectively). ^ The risk of isolated lower limb CLRDs in Texas was significantly lower in females when gender was examined individually (crude prevalence odds ratio of 0.57, 95% CI of 0.36-0.91) as well as in relation to all other variables used in the analysis (adjusted prevalence odds ratio of 0.58, 95% CI of 0.36-0.93). ^ Harris County (which includes the Houston metropolitan area) had significantly lower risks of all (upper limb and lower limb combined) isolated CLRDs when examined in relation to other counties in Texas, with a crude prevalence odds ratio of 0.4 (95% CI: 0.29-0.72) and an adjusted prevalence odds ratio of 0.50 (95% CI: 0.31-0.80). The risk of isolated upper limb CLRDs was significantly lower in Harris County (crude prevalence odds ratio of 0.45, CI of 0.26-0.76 and adjusted prevalence odds ratio of 0.49, CI of 0.28-0.84). This trend toward decreased risk in Harris County was not observed for isolated lower limb reduction defects (adjusted prevalence odds ratio of 0.50, 95% confidence interval: 0.22-1.12). ^ Conclusions. The birth prevalence of isolated congenital limb reduction defects in Texas is in the lower limits of the range of rates that have been reported by other authors for other states (Alabama, Arkansas, California, Georgia, Hawaii, Iowa, Maryland, Massachusetts, North Carolina, Oklahoma, Utah, Washington) and other countries (Argentina, Australia, Austria, Bolivia, Brazil, Canada, Chile, China, Colombia, Costa Rica, Croatia, Denmark, Ecuador, England, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Lithuania, Mexico, Norway, Paraguay, Peru, Spain, Scotland, Sweden, Switzerland, Uruguay, and Venezuela). In Texas, the birth prevalence of isolated congenital lower limb reduction defects was greater for males than females, while the birth prevalence of isolated congenital upper limb reduction defects was not significantly different between males and females. The reduced rates of limb reduction defects in Harris County warrant further investigation. This study has provided an important first step toward gaining etiologic understanding in the study of isolated congenital limb reduction defects. ^

Two Obstetrical Heresies

Dr. Silas F. Starley deplores what he considered errors generally taught and accepted in the late 19th century in Two Obstetrical Heresies . “The first is the part that membranes containing the amniotic fluid and the foetus play in effecting dilation of the os uteri in the first stage of labor.The second is the supposed necessity for waiting for their rupture and the escape of the waters before applying the forceps, in every case, without exception.” Silas F. Starley (1823-1887) was born in Alabama and moved to Texas with his family in 1837. He graduated from the University of Louisville School of Medicine in 1854 and spent his professional career in Texas, ending his career in Corsicana. He was President of the State Medical Association of Texas (Texas Medical Association) in 1883 and wrote articles in Texas medical journals on various topics including obstetrics, vascular tumor, and pneumonia. Texas State Historical Association, http://www.tshaonline.org/handbook/online/articles/sat05 , accessed 10/16/2012. Texas Physicians Historical Biographical Database, http://www4.utsouthwestern.edu/library/doctors/doctors.cfm?DoctorID=16809 , accessed 10/16/12.